Loving-kindness Meditation for Posttraumatic Stress Disorder (PTSD)

A before and after study of veterans who took part in a 12-week loving-kindness meditation course as an adjunct to their usual care for posttraumatic stress disorder.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Posttraumatic Stress Disorder Behavior Behavioral Symptoms Depression Mental Disorders Stress Disorders, Post-Traumatic Stress Disorders, Traumatic Trauma and Stressor Related Disorders

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

VA Puget Sound

Seattle, Washington, 98108, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

posttraumatic stress disorder

Exclusion criteria

psychosis
borderline personality disorder

Treatment and study plan

Loving-kindness Meditation

Behavioral

A 12-week duration, 90 minute per session loving-kindness meditation course

Primary outcomes

change in PTSD symptoms

Time frame: baseline, post-intervention, 3-month follow-up

The PTSD symptom-scale interview was performed
change in depressive symptoms

Time frame: baseline, post-intervention, 3-month follow-up

The PROMIS measure for depression was administered

Sponsors and collaborators

Lead sponsor

Seattle Institute for Biomedical and Clinical Research

Other

Registry information

Official study title

An Open Pilot Study of Loving-Kindness Meditation for PTSD

Important dates

Study start: 2010
Primary completion: 2011
Study completion: 2011
First posted: May 30, 2012
Registry last updated: May 30, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed